CL Amundsen, YM Komesu, C Chermansky… - European urology, 2018 - Elsevier
Background Urgency urinary incontinence (UUI) is a chronic condition for which sacral neuromodulation (SNM)(InterStim/Medtronic) and onabotulinumtoxinA …
R Raju, BJ Linder - Mayo Clinic Proceedings, 2020 - Elsevier
Overactive bladder (OAB) is a symptom complex that includes urinary urgency, frequency, urgency incontinence, and nocturia. It is highly prevalent, affecting up to 12% of the adult …
J Jankovic, J Carruthers, M Naumann, P Ogilvie… - Toxins, 2023 - mdpi.com
Though the formation of neutralizing antibodies (NAbs) during treatment with botulinum neurotoxin is rare, their presence may nonetheless affect the biological activity of botulinum …
V Nitti, C Haag-Molkenteller, M Kennelly, M Chancellor… - Medicine, 2023 - journals.lww.com
Neurogenic detrusor overactivity (NDO) is a complication of multiple sclerosis, spinal cord injury (SCI), stroke, head injury, and other conditions characterized by damage to the upper …
O Yokoyama, M Honda, T Yamanishi… - … Journal of Urology, 2020 - Wiley Online Library
Objective To evaluate the efficacy and safety of onabotulinumtoxinA (botulinum toxin type A) 100 U in patients with overactive bladder and urinary incontinence. Methods This was a …
P Miotla, R Cartwright, K Skorupska… - International …, 2017 - Springer
Introduction and hypothesis Intravesical onabotulinumtoxinA (Botox) injections are effective for the treatment of idiopathic overactive bladder (OAB) symptoms. The aim of our study was …
JC Truzzi, MC Lapitan, NC Truzzi… - Neurourology and …, 2022 - Wiley Online Library
Purpose We sought to systematically review the literature on the use of botulinum toxin (BTX‐ A) injections in the bladder to treat overactive bladder (OAB) in men. Materials and methods …